Found: 3
Select item for more details and to access through your institution.
Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.787748
- By:
- Publication type:
- Article
Letter: serum HBV RNA and HBcrAg may help to evaluate safely stopping nucleot(s)ide analogues in patients with HBeAg‐negative chronic hepatitis B and without cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1219, doi. 10.1111/apt.17154
- By:
- Publication type:
- Article
Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.901233
- By:
- Publication type:
- Article